Metformin Therapy Center - Diabetes In Control

Which Oral Meds Are Best At Reducing HbA1c?

Oct 29, 2019 Blood Glucose Control, Metformin Therapy Center, Sulfonylurea

Data from this study shows the effects of oral diabetes medications on HbA1C levels from two separate cohort groups.

Medications That Can Reduce The Conversion To Type 2 Diabetes

Oct 12, 2019 Type 2 Diabetes, Metformin Therapy Center

Pharmacological interventions may have a role to play in preventing progression to type 2 diabetes, but are they more important than lifestyle factors?

Metformin and Varicose Vein Risk

Oct 5, 2019 Paid, Metformin Therapy Center

First study to examine whether the diabetes drug may have anti-inflammatory properties that affect varicose vein risk.

Clinical Inertia is Doubled in Patients of Asian Ethnicity with Type 2 Diabetes

Oct 5, 2019 Blood Glucose Control, Metformin Therapy Center

Study finds U.S. patients of Asian ancestry are experiencing delays in treatment augmentation when they haven’t met the recommended hemoglobin A1c goals.

Metformin Found to Reduce Risk of Dementia in T2DM

Aug 10, 2019 Type 2 Diabetes, Geriatric Medicine, Paid, Metformin Therapy Center

Could metformin potentially be the first medication approved to PREVENT dementia?

Promising Results In A Phase 3 First-in-Class Oral Diabetic Drug

Jul 20, 2019 Type 2 Diabetes, Paid, Metformin Therapy Center

How does Imeglimin perform in combination with metformin in patients with type 2 diabetes?

Is There an Ongoing Effect After Beta-cell Function Treatment Withdrawal? — ADA

Jun 25, 2019 Paid, Metformin Therapy Center

Evidence has shown diabetic treatment options to improve beta-cell function and/or insulin sensitivity, but do these effects persist upon treatment withdrawal?